What is the recommended management of labial herpes (herpes simplex virus type 1) in pregnant women, including treatment of primary and recurrent episodes, suppressive therapy, and delivery planning?

Medical Advisory BoardAll articles are reviewed for accuracy by our Medical Advisory Board
Educational purpose only • Exercise caution as content is pending human review
Article Review Status
Submitted
Under Review
Approved

Last updated: May 1, 2026 • View editorial policy

Have a follow-up question?

Our Medical A.I. is used by practicing medical doctors at top research institutions around the world. Ask any follow up question and get world-class guideline-backed answers instantly.

Management of Labial Herpes in Pregnancy

Labial herpes (HSV-1) in pregnant women can be treated with oral acyclovir for symptomatic episodes, with no routine suppressive therapy needed unless infections are severe or frequent, and vaginal delivery is safe unless active genital lesions are present at labor.

Treatment Approach

For Active Labial Herpes Episodes

Oral acyclovir is the treatment of choice for symptomatic labial herpes during pregnancy 1. While the safety of systemic acyclovir has not been formally established in pregnancy, current registry findings show no increased risk for major birth defects compared to the general population 1. The accumulated safety data provides reassurance, though the sample size remains insufficient for definitive conclusions.

  • Primary or first clinical episode: Treat with oral acyclovir 1
  • Recurrent labial episodes: Treatment is optional and based on symptom severity
  • Life-threatening HSV infection (disseminated infection, encephalitis, pneumonitis, hepatitis): IV acyclovir is indicated 1

Suppressive Therapy Considerations

Routine suppressive acyclovir for recurrent labial herpes is NOT recommended during pregnancy 1. However, suppressive therapy may be considered for:

  • Women with frequent or severe recurrences (≥6 episodes per year) 2
  • Patients requiring treatment for significant pain or functional impairment

The evidence supporting suppressive therapy near term applies primarily to genital herpes to reduce cesarean delivery rates, not labial herpes 1.

Key Safety Information

Acyclovir remains pregnancy category B 3. Important caveats:

  • Women receiving acyclovir during pregnancy should be reported to the pregnancy registry 1
  • Valacyclovir and famciclovir have insufficient pregnancy data 1
  • One case-control study suggested increased gastroschisis risk with antiherpes medications used periconceptionally, though confounding factors and recall bias limit interpretation 3

Delivery Planning

The critical distinction is between labial and genital herpes:

For Labial Herpes Only (No Genital Involvement)

  • Vaginal delivery is appropriate regardless of active labial lesions 1
  • Active cold sores on the lips do NOT require cesarean delivery
  • The risk of neonatal transmission from labial herpes is negligible during vaginal delivery

If Genital Lesions Are Present

  • Examine carefully at labor onset for any genital lesions or prodromal symptoms 1
  • Cesarean delivery is indicated if active genital lesions or prodrome are present at labor 1
  • The highest transmission risk (30-50%) occurs with newly acquired genital HSV near delivery 1

Critical Pitfalls to Avoid

  1. Do not confuse labial with genital herpes management: Labial lesions alone do not require cesarean delivery or suppressive therapy near term

  2. Do not perform routine viral cultures during pregnancy: Culture results do not predict viral shedding at delivery and are not indicated 1

  3. Counsel about preventing NEW genital HSV acquisition: Pregnant women should avoid unprotected genital and oral sexual contact during late pregnancy if partners have oral or genital HSV 1. This is the most important prevention strategy since primary genital infection near term carries the highest neonatal risk.

  4. Do not withhold treatment for severe maternal disease: IV acyclovir is indicated for life-threatening maternal HSV infections regardless of pregnancy status 1

Practical Management Algorithm

At any prenatal visit with active labial herpes:

  • Offer oral acyclovir for symptom relief if desired
  • Counsel on hygiene (handwashing, avoiding kissing newborn during active lesions)
  • Reassure about vaginal delivery safety

At labor onset:

  • Examine for genital lesions (not just labial)
  • Question about genital prodromal symptoms
  • If no genital involvement → proceed with vaginal delivery
  • If genital lesions present → cesarean delivery

Postpartum:

  • Counsel on avoiding direct contact between active labial lesions and newborn
  • Handwashing before handling infant
  • Can breastfeed if no breast lesions present

The evidence consistently shows that labial herpes poses minimal risk to the neonate during vaginal delivery, unlike genital herpes which requires careful assessment and potential cesarean delivery 1.

Professional Medical Disclaimer

This information is intended for healthcare professionals. Any medical decision-making should rely on clinical judgment and independently verified information. The content provided herein does not replace professional discretion and should be considered supplementary to established clinical guidelines. Healthcare providers should verify all information against primary literature and current practice standards before application in patient care. Dr.Oracle assumes no liability for clinical decisions based on this content.